Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio

Diabetes

Volumn 54, Issue 4, 2005, Pages 976-984

  Shao, Jianhua ^a   Qiao, Liping ^a   Janssen, Rachel C ^a   Pagliassotti, Michael ^b   Friedman, Jacob E ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIC AMP; DEXAMETHASONE; GLUCOSE; MESSENGER RNA;

ARTICLE; CHROMATIN STRUCTURE; CHRONICITY; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; HORMONAL REGULATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CELL; LIVER CELL CARCINOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PEPCK GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSCRIPTION REGULATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE; HYPERGLYCEMIA; LIVER; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 15944429983     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.4.976     Document Type: Article

References (34)

1. Nordlie RC, Foster JD, Lange AJ: Regulation of glucose production by the liver. Annu Rev Nutr 19:379-406, 1999
2. Vidal-Puig A, O'Rahilly S: Metabolism: controlling the glucose factory. Nature 413:125-126, 2001
3. Scott DK, O'Doherty RM, Stafford JM, Newgard CB, Granner DK: The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism. J Biol Chem 273: 24145-24151, 1998
4. Hanson RW, Reshef L: Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 66:581-611, 1997
5. Kahn CR, Lauris V, Koch S, Crettaz M, Granner DK: Acute and chronic regulation of phosphoenolpyruvate carboxykinase mRNA by insulin and glucose. Mol Endocrinol 3:840-845, 1989
6. Kim JK, Zisman A, Fillmore JJ, Peroni OD, Kotani K, Perret P, Zong H, Dong J, Kahn CR, Kahn BB, Shulman GI: Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest 108:153-160, 2001
7. Nawano M, Oku A, Ueta K, Umebayashi I, Ishirahara T, Arakawa K, Saito A, Anai M, Kikuchi M, Asano T: Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. Am J Physiol Endocrinol Metab 278:E535-E543, 2000
8. Hawkins M, Gabriely I, Wozniak R, Reddy K, Rossetti L, Shamoon H: Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects. Diabetes 51:2179-2189, 2002
9. Croniger C, Trus M, Lysek-Stupp K, Cohen H, Liu Y, Darlington GJ, Poli V, Hanson RW, Reshef L: Role of the isoforms of CCAAT/enhancer-binding protein in the initiation of phosphoenolpyruvate carboxykinase (GTP) gene transcription at birth. J Biol Chem 272:26306-26312, 1997
10. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ: Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269:1108-1112, 1995
11. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM: Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423:550-555, 2003
12. Chen C, Dudenhausen EE, Pan Y, Zhong C, Kilberg MS: Human CCAAT/ enhancer-binding protein beta (C/EBPbeta) gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence. J Biol Chem 279: 27948-27956, 2004
13. Duong DT, Waltner-Law ME, Sears R, Sealy L, Granner DK: Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 277:32234-32242, 2002
14. Croniger C, Leahy P, Reshef L, Hanson RW: C/EBP and the control of phosphoenolpyruvate carboxykinase gene transcription in the liver. J Biol Chem 273:31629-31632, 1998
15. Descombes P, Schibler U: A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569-579, 1991
16. Arizmendi C, Liu S, Croniger C, Poli V, Friedman JE: The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 274:13033-13040, 1999
17. Park EA, Roesler WJ, Liu J, Klemm DJ, Gurney AL, Thatcher JD, Shuman J, Friedman A, Hanson RW: The role of the CCAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP). Mol Cell Biol 10:6264-6272, 1990
18. Deng L, Lin-Lee YC, Claret FX, Kuo MT: 2-Acetylaminofluorene upregulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway. J Biol Chem 276:413-420, 2001
19. Jackson TA, Schweppe RE, Koterwas DM, Bradford AP: Fibroblast growth factor activation of the rat PRL promoter is mediated by PKCdelta. Mol Endocrinol 15:1517-1528, 2001
20. Nissen RM, Yamamoto KR: The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14:2314-2329, 2000
21. DeFronzo RA, Simonson D, Ferrannini E: Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313-319, 1982
22. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D: Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74:1238-1246, 1984
23. DeFronzo RA: Lilly Lecture 1987: The triumvirate: beta-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
24. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA: Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515, 1987
25. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM: Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-138, 2001
26. Yamada K, Duong DT, Scott DK, Wang J-C, Granner DK: CCAAT/enhancer- binding protein beta is an accessory factor for the glucocorticoid response from the cAMP response element in the rat phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 274:5880-5887, 1999
27. Patel YM, Yun JS, Liu J, McGrane MM, Hanson RW: An analysis of regulatory elements in the phosphoenolpyruvate carboxykinase (GTP) gene which are responsible for its tissue-specific expression and metabolic control in transgenic mice. J Biol Chem 269:5619-5628, 1994
28. Scott DK, Stromstedt PE, Wang JC, Granner DK: Further characterization of the glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene: the role of the glucocorticoid receptor-binding sites. Mol Endocrinol 12:482-491, 1998
29. Wang JC, Stromstedt PE, O'Brien RM, Granner DK: Hepatic nuclear factor 3 is an accessory factor required for the stimulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. Mol Endocrinol 10:794-800, 1996
30. Guo S, Rena G, Cichy S, He X, Cohen P, Unterman T: Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem 274:17184-17192, 1999
31. Chakravarty K, Leahy P, Becard D, Hakimi P, Foretz M, Ferre P, Foufelle F, Hanson RW: Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase (GTP) gene transcription. J Biol Chem 276:34816-34823, 2001
32. Greenbaum CJ, Prigeon RL, D'Alessio DA: Impaired β-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. Diabetes 51:951-957, 2002
33. Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA: Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 85:4053-4059, 2000
34. Bizeau ME, Short C, Thresher JS, Commerford SR, Willis WT, Pagliassotti MJ: Increased pyruvate flux capacities account for diet-induced increases in gluconeogenesis in vitro. Am J Physiol Reg Integr Comp Physiol 281:R427-R433, 2001